Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts).

Authors

null

Alice K Fortune-Greeley

Center for Health Services Research & Development, Durham VA Medical Center, Durham, NC

Alice K Fortune-Greeley , Christina D. Williams , Jessica K Paulus , Michael J. Kelley

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 7568)

DOI

10.1200/jco.2014.32.15_suppl.7568

Abstract #

7568

Poster Bd #

176

Abstract Disclosures

Similar Posters

Poster

2016 Gastrointestinal Cancers Symposium

Effect of metformin on survival in pancreatic ductal adenocarcinoma.

Effect of metformin on survival in pancreatic ductal adenocarcinoma.

First Author: Sunil Amin

First Author: Meredith Ray

First Author: Lawrence N. Shulman